High Preponderance of BRAF V600E Mutation in Papillary Thyroid Carcinoma Among Filipinos: A Clinicopathologic Study

High Preponderance of BRAF V600E Mutation in Papillary Thyroid Carcinoma Among Filipinos: A Clinicopathologic Study

Purpose: BRAF mutation in papillary thyroid carcinoma (PTC) is associated with an aggressive phenotype, with varying incidence. We evaluated the prevalence of BRAF mutations in PTC among Filipino patients and their correlation with clinicopathologic characteristics. Patients and Methods: Clinicopath...

Full description

Bibliographic Details
Main Authors:	Gerard Anthony M. Espiritu, Joemari T. Malana, Arlie Jean Grace V. Dumasis, Daphne C. Ang
Format:	Article
Language:	English
Published:	American Society of Clinical Oncology 2019-01-01
Series:	Journal of Global Oncology
Online Access:	http://ascopubs.org/doi/10.1200/JGO.18.00085

Similar Items

The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients
by: Li-Bo Yang, et al.
Published: (2015-01-01)

Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China
by: Meiling Huang, et al.
Published: (2019-07-01)

Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma.
by: Ah Young Park, et al.
Published: (2014-01-01)

Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series
by: Danielle Pessôa-Pereira, et al.
Published: (2019-03-01)

Clinical significance of BRAF V600E mutation in low risk papillary thyroid carcinoma
by: He-Jiun Jiang, et al.
Published: (2018)

BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients.
by: Jian Sun, et al.
Published: (2016-01-01)

Rare cell detection of BRAF-V600E mutation in the patients with papillary thyroid carcinoma
by: Kong Kit Leong, et al.
Published: (2016)

A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation
by: Jill Pancer, et al.
Published: (2019-03-01)

BRAF V600E and lymph node metastases in papillary thyroid cancer
by: Pan Chen, et al.
Published: (2020-10-01)

Prevalence of BRAF Mutation in Papillary Thyroid Cancer
by: Shatha Dmour, et al.
Published: (2016-12-01)

BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features
by: Chenlei Shi, et al.
Published: (2020-06-01)

BRAF V600E mutation detection for patients with papillary thyroid carcinoma by cell-direct PNA-PCR
by: Yu Ting Chen, et al.
Published: (2017)

Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto’s Thyroiditis
by: Qin Zhang, et al.
Published: (2017-07-01)

Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients
by: Yun Sun, et al.
Published: (2013-01-01)

Meta-Analyses of Association Between BRAFV600E Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma
by: Qing Zhang, et al.
Published: (2016-02-01)

Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma
by: Changjiao Yan, et al.
Published: (2019-07-01)

False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
by: Se Hyun Paek, et al.
Published: (2017-11-01)

Deep Small RNA Sequencing of BRAF V600E Mutated Papillary Thyroid Carcinoma With Lymph Node Metastasis
by: Azliana Mohamad Yusof, et al.
Published: (2019-10-01)

The Clinical Manifestations and Specific Gene Expressions in Conventional Papillary Thyroid Carcinoma with BRAFV600E Mutation and BRAF Pseudogene
by: Shuai-Shuai Fu, et al.
Published: (2012)

Extended Antitumor Responseof a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
by: Siraj M. Ali, et al.
Published: (2014-05-01)

Predicting factors of central lymph node metastasis and BRAF V600E mutation in Chinese population with papillary thyroid carcinoma
by: Sheng Li Zhou, et al.
Published: (2021-07-01)

Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.
by: Artur Kowalik, et al.
Published: (2017-01-01)

BRAF in Papillary Thyroid Carcinoma
by: Salvatore Giovanni Lanzilotta, et al.
Published: (2007-01-01)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
by: Woon Won Kim, et al.
Published: (2018-01-01)

Coexistence of BRAFV600E mutation and EGFR overexpression is highly associated with adverse clinicopathological features of papillary thyroid carcinoma
by: Paunović Ivan, et al.
Published: (2020-01-01)

Correlation of the BRAFV600E and RAS mutations with clinicopathological characteristics of papillary thyroid cancer using TCGA database analysis
by: Yue Zhao, et al.
Published: (2019-01-01)

Coexisting Germline <i>CHEK2</i> and Somatic <i>BRAF</i><sup>V600E</sup> Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course
by: Danuta Gąsior-Perczak, et al.
Published: (2019-11-01)

Clinicopathological Significance of BRAF (V600E), NRAS (Q61K) and TERT (C228T, C250T and SNP Rs2853669) Mutations in Bulgarian Papillary Thyroid Carcinoma Patients
by: Vidinov K., et al.
Published: (2021-04-01)

Effect of BRAF<sup>V600E </sup>mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model
by: Guenther Simone M, et al.
Published: (2007-03-01)

BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.
by: Suhail Al-Salam, et al.
Published: (2020-01-01)

BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry
by: Ana P Estrada-Flórez, et al.
Published: (2019-09-01)

BRAF mutation in papillary carcinoma of the thyroid: Clinical implication and cytomorphology correlation
by: Kung-Jen Huang, et al.
Published: (2006)

BRAF mutation in papillary thyroid microcarcinoma – additional marker of risk stratification
by: Dmitriy Yuriyevich Semyonov, et al.
Published: (2014-11-01)

Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAFV600E Mutation and Clinicopathological Features
by: Li G, et al.
Published: (2020-05-01)

Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
by: Chenlei Shi, et al.
Published: (2016-01-01)

BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases
by: Najla Fakhruddin, et al.
Published: (2017-07-01)

BRAFV600E mutation in anaplast thyroid carcinomas and multiple papillary thyroid carcinomas
by: Po-chin Tsai, et al.
Published: (2005)

A BRAF V600E Mutation in RET-Negative Medullary Thyroid Cancer
by: Richard J. Robbins, et al.
Published: (2020-01-01)

The role of BRAF V600 mutation in melanoma
by: Ascierto Paolo A, et al.
Published: (2012-07-01)

BRAF V600E expression found in aggressive papillary thyroid carcinoma (PTC), lymph node metastasis, and extra-thyroid extension
by: Made Priska Rusmana, et al.
Published: (2018-10-01)

Cannot write session to /tmp/vufind_sessions/sess_sg5i08fc5aaa8ip72sb54e1fcb